Indirect-response model for the time course of leukopenia with anticancer drugs. (Q52230502)

27 April 2018

title

Indirect-response model for the time course of leukopenia with anticancer drugs. (English)

1 reference

27 April 2018

author name string

Minami H

1

1 reference

27 April 2018

Sasaki Y

2

1 reference

27 April 2018

Saijo N

3

1 reference

27 April 2018

Ohtsu T

4

1 reference

27 April 2018

Fujii H

5

1 reference

27 April 2018

Igarashi T

6

1 reference

27 April 2018

Itoh K

7

1 reference

27 April 2018

language of work or name

English

0 references

publication date

1 November 1998

1 reference

27 April 2018

Clinical Pharmacology & Therapeutics

published in

1 reference

27 April 2018

volume

64

1 reference

27 April 2018

issue

5

1 reference

27 April 2018

page(s)

511-521

1 reference

27 April 2018

Quantitative Relationships Between Circulating Leukocytes and Infection in Patients with Acute Leukemia

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990134-5

Kinetics of pharmacologic response

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990134-5

Kinetics of pharmacologic effects in man: The anticoagulant action of warfarin

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990134-5

Phase I and pharmacokinetic study of paclitaxel by 24-hour intravenous infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990134-5

Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to d-tubocurarine

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990134-5

Pharmacodynamics in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990134-5

Modeling interpatient pharmacodynamic variability of etoposide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990134-5

Clinical and pharmacologic analysis of hyperfractionated daily oral etoposide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990134-5

Nonlinear pharmacokinetics and metabolism of paclitaxel and its pharmacokinetic/pharmacodynamic relationships in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990134-5

Pharmacokinetics of paclitaxel and metabolites in a randomized comparative study in platinum-pretreated ovarian cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990134-5

Phase I clinical and pharmacokinetic study of a 14-day infusion of etoposide in patients with lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990134-5

Pharmacodynamic modeling of prolonged administration of etoposide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990134-5

Comparison of four basic models of indirect pharmacodynamic responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990134-5

Physiologic indirect response models characterize diverse types of pharmacodynamic effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990134-5

Pharmacokinetics and pharmacodynamic modeling of direct suppression effects of methylprednisolone on serum cortisol and blood histamine in human subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990134-5

LEUKOKINETIC STUDIES. II. A METHOD FOR LABELING GRANULOCYTES IN VITRO WITH RADIOACTIVE DIISOPROPYLFLUOROPHOSPHATE (DFP)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990134-5

Some suggestions for measuring predictive performance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990134-5

Mathematical model for in vivo pharmacodynamics integrating fluctuation of the response: application to the prolactin suppressant effect of the dopaminomimetic drug DCN 203-922.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990134-5

Pharmacodynamic analysis of hematologic profiles.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990134-5

A population model for the leukopenic effect of etoposide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990134-5

A general model for time-dissociated pharmacokinetic-pharmacodynamic relationship exemplified by paclitaxel myelosuppression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990134-5

A randomized trial to evaluate the effect of schedule on the activity of etoposide in small-cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990134-5

10.1016/S0009-9236(98)90134-5

7 January 2021

Identifiers

DOI

1 reference

27 April 2018

1 reference

27 April 2018